Induced pluripotency of mouse and human somatic cells

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 73, Issue , 2008, Pages 157-162

  Maherali, N ^a,b   Hochedlinger, K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CONFERENCE PAPER; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SOMATIC CELL; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; MOUSE; PHYSIOLOGY; REVIEW; CELLS BY BODY ANATOMY; INDUCED PLURIPOTENT STEM CELL; MEDICAL LITERATURE; NUCLEAR REPROGRAMMING;

IPS;

ANIMALS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; MICE; MODELS, BIOLOGICAL; MUTAGENESIS, INSERTIONAL; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

EID: 68549094635     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2008.73.017     Document Type: Conference Paper

References (50)

1. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T., and Yamanaka, S. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702
2. Blelloch, R., Venere, M., Yen, J., and Ramalho-Santos, M. 2007. Generation of induced pluripotent stem cells in the absence of selection. Cell Stem Cell 1: 245-247.
3. Brambrink, T., Hochedlinger, K., Bell, G., and Jaenisch, J. 2006. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc. Natl. Acad. Sci. 103: 933-938.
4. Brambrink, T., Foreman, R., Welstead, G.G., Lengner, C.J., Wernig, M., Suh, H., and Jaenisch, R. 2008. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151-159.
5. Cowan, C.A., Atienza, J., Melton, D.A., and Eggan, K. 2005. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369-1373.
6. Davis, R.L., Weintraub, H., and Lassar, A.B. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.
7. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
8. Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A. 2004. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46.
9. Eggan, K., Akutsu, H., Hochedlinger, K., Rideout III, W., Yanagimachi, R., and Jaenisch, R. 2000. X-Chromosome inactivation in cloned mouse embryos. Science 290: 1578-1581.
10. Eminli, S., Utikal, J.S., Arnold, K., Jaenisch, R., and Hochedlinger, K. 2008. Reprogramming of neural progenitor cells into iPS cells in the absence of exogenous Sox2 expression. Stem Cells (in press).
11. Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E.V., Bronson R.T., and Pellman, D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043-1047.
12. Hanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., Beard, C., Brambrink, T., Wu, L.C., Townes, T.M., and Jaenisch, R. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
13. Hanna, J., Markoulaki, S., Schorderet, P., Carey, B.W., Beard, C., Wernig M., Creyghton, M.P., Steine E.J., Cassady, J.P., Foreman, R., et al. 2008. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264.
14. Hawley, R.G. 2008. Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? Mol. Ther. 16: 1354-1355.
15. Hochedlinger, K. and Jaenisch, R. 2002a. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415: 1035-1038.
16. Hochedlinger, K. and Jaenisch, R. 2002b. Nuclear transplantation: Lessons from frogs and mice. Curr. Opin. Cell Biol. 14: 741-748.
17. Hochedlinger, K. and Jaenisch, R. 2003. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 349: 275-286
18. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen A.E., and Melton, D.A. 2008. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26: 795-797.
19. Kim, J.B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., Arauzo-Bravo, M.J., Ruau, D., Han, D.W., Zenke, M., and Scholer, H.R. 2008. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650
20. Kopp, J.L., Ormsbee, B.D., Desler, M., and Rizzino, A. 2008. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26: 903-911.
21. Kustikova, O., Fehse, B., Modlich, U., Yang, M., Dullmann, J., Kamino, K., von Neuhoff, N., Schlegelberger, B., Li, Z., and Baum, C. 2005. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174.
22. Laiosa, C.V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L., and Graf, T. 2006. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25: 731-744.
23. Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J., Sridharan, R., Clark, A.T., and Plath, K. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. 105: 2883-2888.
24. Maherali,N., Sridharan, R.,Xie,W.,Utikal, J., Eminli, S.,Arnold, K., Stadtfeld,M.,Yachechko, R., Tchieu, J., Jaenisch, R., Plath, K., and Hochedlinger, K. 2007. Directly reprogrammed fibroblasts show global epigenetic reprogramming and widespread tissue contribution. Cell Stem Cell 1: 55-70.
25. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C.A., and Hochedlinger, K. 2008. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340-345.
26. Meissner, A., Wernig, M., and Jaenisch, R. 2007. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25: 1177-1181.
27. Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B.E., Jaenisch, R., Lander, E.S., and Meissner, A. 2008. Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 794.
28. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., and Yamanaka, S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
29. Niwa, H., Miyazaki, J., and Smith, A.G. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24: 372-376.
30. Nutt, S.L., Heavey, B., Rolink, A.G., and Busslinger, M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556-562.
31. Okita, K., Ichisaka, T., and Yamanaka, S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
32. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K., and Daley, G.Q. 2008a. Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
33. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W., and Daley, G.Q. 2008b. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
34. Rideout III, W.M., Hochedlinger, K., Kyba, M., Daley, G.Q., and Jaenisch, R. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.
35. Shi, Y., Do, J.T., Desponts, C., Hahm, H.S., Scholer, H.R., and Ding, S. 2008. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528.
36. Silva, J., Chambers, I., Pollard, S., and Smith, A. 2006. Nanog promotes transfer of pluripotency after cell fusion. Nature 441: 997-1001.
37. Stadtfeld, M., Brennand, K., and Hochedlinger, K. 2008a. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol. 18: 890-894.
38. Stadtfeld, M., Maherali, N., Breault, D.T., and Hochedlinger, K. 2008b. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2: 230-240.
39. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hochedlinger, K. 2008. Induced pluripotent stem cells generated without viral integration. Science (in press).
40. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., and Tada, T. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11: 1553-1558.
41. Takahashi, K. and Yamanaka, S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
42. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
43. Wakayama, T., Perry, A.C., Zuccotti, M., Johnson, K.R., and Yanagimachi, R. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394: 369-374.
44. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B.E., and Jaenisch, R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-celllike state. Nature 448: 318-324.
45. Wernig, M., Lengner, C.J., Hanna, J., Lodato, M.A., Steine, E.J., Foreman, R., Staerk, J., Markoulaki, S., and Jaenisch, R. 2008a. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26: 916-924.
46. Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., and Jaenisch, R. 2008b. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. 105: 5856-5861.
47. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., and Campbell, K.H. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813.
48. Xie, H., Ye, M., Feng, R., and Graf, T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
49. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., and Thomson, J.A. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
50. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., and Melton, D.A. 2008. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455: 627-632.